277 (Januvia 100 mg)
Generic Name: sitagliptin
Pill imprint 277 has been identified as Januvia 100 mg.
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 277 (Januvia 100 mg)
- Generic Name:
- 100 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Merck & Company Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
ferric oxide red
sodium stearyl fumarate
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54569-5925||A S Medication Solutions LLC (repackager)|
|54868-5840||Physicians Total Care Inc (repackager)|
|35356-0103||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.